Enhanced Metabolite Profiling from Bark of Alangium Salviifolium Using LC/MS and GC/Q-TOF Techniques

Significance of the Topic

Alangium salviifolium is a medicinal plant long used in Ayurvedic and Chinese traditional medicine against a range of disorders including cancer, microbial infections, diabetes, and inflammatory conditions. A detailed, untargeted metabolite profiling of its bark can reveal bioactive compounds responsible for its therapeutic effects and support the development of novel natural-product-based treatments and quality-controlled herbal formulations.

Objectives and Study Overview

This study aimed to perform comprehensive, untargeted metabolite profiling of A. salviifolium bark extracts using complementary liquid chromatography–mass spectrometry (LC/MS) and gas chromatography/quadrupole time-of-flight (GC/Q-TOF) techniques. Key goals included:

• Maximize detection coverage of polar and nonpolar metabolites through biphasic solvent extraction and fraction collection.
• Apply orthogonal chromatographic chemistries and dual ionization modes for exhaustive LC/MS/MS analysis.
• Leverage GC/Q-TOF with retention-time locked derivatization to identify volatile and semi-volatile components.
• Annotate metabolites via spectral libraries (METLIN, Fiehn, Wiley/NIST) and confirm unreported structures with Agilent MassHunter MSC.

Methodology and Instrumentation

The workflow involved:

• Biphasic extraction with chloroform–methanol–water (1:2.5:1, v/v/v) to separate aqueous and organic fractions.
• Fraction collection on an Agilent 1260 Analytical Scale Fraction Collection System, using time-based slicing into 96-well plates.
• LC/MS/MS analysis on an Agilent 1260 Infinity LC coupled to a 6540 Accurate-Mass Q-TOF in positive and negative AJS-ESI modes.
• Chromatographic separation using four columns: HILIC (Poroshell 120 HILIC Plus), and three reversed phases (ZORBAX SB-Aq, Eclipse Plus C18, Eclipse Plus Phenyl-Hexyl).
• GC/Q-TOF analysis on an Agilent 7200 GC/Q-TOF after derivatization and retention-time locking with d27-myristic acid.
• Data processing with MassHunter Qualitative Analysis, MassHunter Unknown Analysis, Mass Profiler Professional, and MSC software.

Used Instrumentation

• Agilent 1260 Infinity Analytical Scale Fraction Collection System with Manual FL-Injection valve
• Agilent 1260 Infinity LC System
• Agilent 6540 Accurate-Mass Q-TOF LC/MS
• Agilent 7200 GC/Q-TOF with retention-time locking (RTL) software
• Columns: Poroshell 120 HILIC Plus; ZORBAX RRHD SB-Aq; ZORBAX RRHD Eclipse Plus C18; ZORBAX RRHD Eclipse Plus Phenyl-Hexyl; DB-5ms GC column

Main Results and Discussion

• Total of 1 016 molecular features detected: 954 by accurate-mass LC/MS, of which 449 were confirmed by MS/MS; 62 compounds identified via GC/Q-TOF.
• 511 metabolites were structurally annotated; 81 compounds are reported to exhibit therapeutic activities (anticancer, antimicrobial, anti-inflammatory, antioxidant, antidiabetic, etc.).
• Orthogonal LC chemistries contributed uniquely: ZORBAX C18 yielded 197 matches, SB-Aq 187, HILIC 175, Phenyl-Hexyl 139, with limited overlap (10 compounds common to all four).
• Dual ionization improved coverage: positive and negative modes each detected distinct sets of metabolites, with fewer than nine overlapping features per column.
• MSC software enabled putative assignment of five Alangium-specific alkaloids not present in METLIN MS/MS library, achieving overall scores > 97%.

Practical Benefits and Applications

This integrated approach delivers expanded metabolome coverage essential for:

• Natural-product drug discovery by revealing novel bioactive scaffolds.
• Standardization and quality control of herbal medicines through comprehensive chemical fingerprints.
• Investigating mechanisms of therapeutic action via correlation of metabolites with bioactivities.

Future Trends and Potential Applications

Emerging directions include:

• High-throughput, automated fractionation and multi-omics integration (proteomics, transcriptomics) for systems-level insight.
• Machine-learning-driven metabolite annotation to accelerate identification in large spectral libraries.
• Target-ed MS workflows for quantitation of key bioactives and pharmacokinetic studies.
• Development of public databases enriched with retention-time, collision cross-section, and fragmentation metadata.

Conclusion

A synergistic LC/MS and GC/Q-TOF strategy combined with biphasic extraction, orthogonal separations, and advanced data-analysis tools significantly enhances the detection and identification of metabolites in A. salviifolium bark. This workflow provides a robust platform for natural-product research, quality control of herbal preparations, and discovery of therapeutically relevant compounds.

References

1. Hung T.M., et al. Phenolic glycosides from Alangium salviifolium leaves with inhibitory activity on LPS-induced NO, PGE2, and TNF-α production. Bioorg Med Chem Lett. 2009;19(15):4389–4393.
2. Anjum A., et al. Antibacterial compounds from the flowers of Alangium salviifolium. Fitoterapia. 2002;73(6):526–528.
3. Sharma A.K., et al. Antidiabetic effect of bark of Alangium salvifolium in alloxan-induced diabetic rats. J Global Pharma Tech. 2011;3(4):26–32.
4. Murugan V., et al. Anti-fertility activity of the stem bark of Alangium salviifolium (Linn. f.) Wang in Wistar female rats. Indian J Pharmacol. 2000;32:388–389.
5. Commisso M., et al. Untargeted metabolomics: an emerging approach to determine the composition of herbal products. Comput Struct Biotechnol J. 2013;4(5):e201301007.
6. Palazoglu M., Fiehn O. Metabolite identification in blood plasma using GC/MS and the Agilent Fiehn GC/MS metabolomics RTL library. Agilent Technologies Application Note. 2009;5990-3638EN.
7. Aurand C.R., et al. Metabolomic profiling of Neurospora crassa fungi using HILIC and reversed-phase LC/MS. Agilent Reporter. 2014;56:13–14.